Search for: "LILLI JOHNSON" Results 101 - 120 of 243
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
6 May 2011, 8:37 am by Kara OBrien
Johnson & Johnson, previously included in the group of companies under investigation, resolved an FCPA enforcement action last month and Koehler thinks their enforcement action provides a glimpse into potential future FCPA enforcement actions involving the pharmaceutical/medical device industry. [read post]
22 Sep 2011, 3:39 am by Bob Kraft
” The story reports on payments by Eli Lilly and Co., down 46 percent since 2009; GlaxoSmithKline down 29 percent. [read post]
20 Sep 2011, 3:52 am by Bob Kraft
" The story reports on payments by Eli Lilly and Co., down 46 percent since 2009; GlaxoSmithKline down 29 percent. [read post]
5 May 2011, 1:57 am by Kevin LaCroix
Last week, Eli Lilly. disclosed that it is in “advanced discussions” to settle bribery related allegations. [read post]
1 Jun 2017, 9:45 am by Barbara Moreno
PSYCHOLOGY AND PSYCHIATRY Singh, Lilly, How to be a Bawse: A Guide to Conquering Life (2017). [read post]
3 Dec 2009, 12:13 am
Marketing Tactics Put Johnson & Johnson Under DOJ Microscope The Recorder Four years after the first subpoena, the government's investigation of health care fraud at Johnson & Johnson has reached zero hour. [read post]
9 Mar 2012, 1:12 pm by Pilar G. Kraman
Other speakers include: • David Kappos, undersecretary of commerce for intellectual property and director, USPTO • Judge Paul Michel • Gary Griswold, president and chief intellectual property counsel, 3M Innovative Properties Company and former chairman, 21st Century Patent Reform • Bob Stoll, former commissioner, USPTO and partner, Drinker Biddle & Reath • Robert Armitage, senior VP and general counsel, Eli Lilly • Steven Wood, patent… [read post]
9 Apr 2009, 7:52 am
(Part I - Patent Circle) (Part II – Patent Circle) Indian biogenerics on an upswing – US Promoting Innovation and Access to Life-Saving Medicine Act (Patent Baristas) US: Anti-reverse payment legislation Protecting Consumer Access to Generic Drugs Act of 2009 introduced in the House (Patent Docs) US: CAFC clarifies obviousness standard in context of cDNA cloning invention: In re Kubin (Holman's Biotech IP Blog) (Patent Docs) (Hal Wegner) (Philip Brooks' Patent… [read post]
11 Dec 2019, 2:00 am by Julie Adams, FordHarrison
Moreover, pay equity continues to be a hot topic for Lilly Ledbetter, as well as many federal agencies. [read post]
10 Aug 2017, 3:41 pm
UK Supreme Court moves towards a UK Doctrine of Equivalents in Lilly pemetrexed battle? [read post]
19 Jul 2007, 1:45 pm
Concerns by 3M Eli Lilly, General Electric, Johnson & Johnson and Proctor & Gamble were muted after amendments to the bill narrowed the “second window” of post-grant reviews. [read post]
30 Jul 2015, 11:50 am by Marcus Mintz
., Corning Incorporated, Eli Lilly and Company, General Electric, Honda, IBM, Illinois Tool Works Inc., Intel, International Fragrance Association, North America, Johnson & Johnson, Medtronic, Micron, National Alliance for Jobs and Innovation (NAJI), National Association of Manufacturers (NAM), NIKE, The Procter & Gamble Company, Siemens Corporation, Software & Information Industry Association (SIIA), U.S. [read post]
12 Aug 2017, 7:44 am by Dean Freeman
In one case, Johnson & Johnson had to pay $2.2 billion to resolve these charges as it pertained to Risperdal, an antipsychotic. [read post]
9 Mar 2009, 4:44 am
Those companies surveyed by Towers Perrin are: Merck, Abbott Laboratories, Amgen, Astra Zeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Hoffman-LaRoche, Johnson & Johnson, Novartis, Pfizer, Sanofi-Aventis, Schering-Plough, and Wyeth.You'll notice that list contains 14 companies â€â [read post]
5 Jun 2007, 10:16 am
”It’s almost everything an infringer could ever want,” says Phil Johnson, the chief patent attorney for J&J. [read post]